Plain-English translation of NCT06120881 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing whether young people with type 2 diabetes need higher doses of than what doctors typically prescribe. Researchers have noticed that teenagers and young adults process this medication faster than older adults do, which means they might benefit from taking more of it. The study will compare the standard dose with a slightly higher dose to see which one helps control blood sugar better.
Most dosing guidelines for this medication were developed based on how older adults respond to treatment. Since young people's bodies work differently, doctors need to know if the current recommended dose is actually the best choice for teenagers and young adults with type 2 diabetes.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to take either the standard dose or the higher dose of the medication for the study period. You'll wear a continuous glucose monitor (a small sensor on your skin) to track your blood sugar levels throughout the day — this helps researchers understand how well each dose is working for you. You'll need to attend training sessions with the study team and follow all their instructions carefully.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States